REQUEST A DEMO
Total
USD $0.00
Search more companies

Farlex Pharmaceuticals Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farlex Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Farlex Pharmaceuticals Private Limited is an enterprise located in India, with the main office in Chandigarh. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on December 10, 2014. From the latest financial highlights, Farlex Pharmaceuticals Private Limited reported a net sales revenue increase of 24.87% in 2025. Its’ total assets recorded a growth of 62.53%. In, 2025, the company’s net profit margin decreased by 0.08%.

Legal Address
Scf 321, 2Nd Floor Motor Market
Chandigarh; Punjab; Postal Code: 160101

Contact Details: Purchase the Farlex Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Farlex Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Farlex Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 10, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Farlex Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
24.87%
Total Operating Revenue
25.22%
Operating Profit
29.61%
EBITDA
21.64%
Net Profit/Loss for the Period
18.15%
Total Assets
62.53%
Total Equity
27.82%
Operating Profit Margin
0.09%
Net Profit Margin
-0.08%
Return on Equity (ROE)
-1.78%
Debt / Equity
177%
Quick Ratio
-0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?